Enable Injections

Enable Injections

Enable Injections is developing the enFuse™ discreet, convenient, body-worn injection device. It is compatible with any standard container closure system, including a syringe or vial and allows self-administration of high-volume (up to 50 mL) and/or high-viscosity therapeutics.

Head Office
Enable Injections Inc
2863 East Sharon Road
Cincinnati
OH 45241
United States

Phone / Contact

T: +1 513 326 2800
E: [email protected]

Connect

Enable Injections develops and manufactures on-body delivery devices that allow patients to self-administer high-volume (up to 50 mL) and/or high-viscosity therapeutics. The company’s devices can be used to bring a new product to market, support lifecycle management (iv to sc; changes to dosing frequency), reduce overall healthcare costs (move from hospital to the home), or to increase product differentiation.

The Enable enFuse™ technology is a discreet body-worn device that provides a comfortable infusion experience allowing the patient to continue with normal daily activities. The Enable system is compatible with any standard container closure system, including a syringe or vial.

Enable Injections was founded in February 2010. It is privately held.

Articles by Enable Injections

ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY

Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.

BEYOND THE POINT: NAVIGATING THE IMPACT OF NEEDLES ON PAIN, ANXIETY AND THE PATIENT EXPERIENCE

Omar Rahman, Mehul Desai and Keith Candiotti discuss the role that needle size plays in the pain and anxiety patients experience during injections and how smaller, hidden needles (30G), such as those employed by Enable Injections’ enFuse large-volume injector, may minimise patient discomfort and maximise subcutaneous injection efficiency.

A NEW FRONTIER: SELF-ADMINISTRATION OF LYOPHILISED, LARGE-VOLUME SUBCUTANEOUS BIOLOGICS

Mehul Desai and Daniel Waites discuss the pros and cons of lyophilisation for biologic injectable drugs, and how Enable Injections’ enFuse device can provide an answer to the challenges of self-injection of large-volume and lyophilised biologics.

REDUCE PHARMA DEVELOPMENT TIME: LARGE-VOLUME SUBCUTANEOUS DELIVERY WITH THE ENFUSE^®

Mehul Desai discusses how Enable Injections' enFuse^® delivery system provides a flexible alternative for subcutaneous administration of high-volume therapeutics.

FLEXIBLE CARE – ENABLE WEARABLE DELIVERY

Jennifer Estep and Mehul Desai discuss the benefits for patients and healthcare providers of innovative subcutaneous delivery.

Matthew Huddleston

DRUG DELIVERY: WHAT DO PATIENTS AND PROVIDERS WANT?

Matthew Huddleston and Jennifer Estep discuss current drug delivery options and the value of convenient care.

THE NEW PATIENT-CENTRICITY

Jennifer Estep discusses the new pressures put on the healthcare system by the covid-19 pandemic, and how patients and healthcare providers alike are turning to patient-centric solutions to minimise risks and ease burdens.

DRUG DELIVERY DESIGNED TO IMPROVE THE PATIENT EXPERIENCE

Jennifer King looks at the delivery challenges of novel therapies for chronic diseases using a specific patient’s story as an example, going on to highlight the ways in which a novel device approach could make all the difference for patients.

Matthew Huddleston

KEY CHALLENGES IN SUCCESSFUL WEARABLE DRUG DELIVERY & PATIENT SELF-ADMINISTRATION

Matthew Huddleston, Andrew Eibling and Jennifer King look at the key challenges involved in successful wearable drug delivery technology and patient self-administration.

PATIENT TOLERABILITY WITH HIGH-VISCOSITY, LARGE-VOLUME SUBCUTANEOUS INFUSIONS

Jennifer King and Matthew J Huddleston discuss the advantages of subcutaneous drug delivery and how these have yet to be fully harnessed in currently marketed therapeutics.

Dr Jeannie Joughin

BIOLOGIC DRUGS AND THEIR DELIVERY SYSTEMS: A SYMBIOSIS KEY TO COMMERCIAL SUCCESS

Jeannie Joughin discusses the ever-growing importance of the delivery system in the biologic combination product area, highlighting how it is the delivery system, not the drug, that defines the patient experience.

ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY

The delivery of high volumes of biologics outside of the clinical setting remains a key challenge in the industry. Here, John Love, Mark Lee and Amy Boyle discuss how the enFuse™ on-body injector, developed by Enable in partnership with Flex, may be the answer.

Dr Jeannie Joughin

WEARABLE INJECTOR PLATFORM: THE CASE FOR EARLY PARTNERING

Jeannie Joughin describes how significant factors and developments have converged leading to the rise of patient-centric healthcare and self-administration, the wearable injector at the cutting edge. Also showing that early clinical partnership with a platform wearable device company is beneficial across numerous criteria, and how this was a key design consideration for Enable’s wearable technology.

Matthew Huddleston

BEYOND CONNECTIVITY: ENABLE & FLEX ANNOUNCE THE ENABLE SMART DEVICE

Matthew J Huddleston and Angela Wright talk about integrating Bluetooth connectivity into Enable’s latest Smart On-Body Delivery Device, describing how the Flex/Enable partnership has also been expanded to encompass Flex’s Digital Health Platform.

Dr Jeannie Joughin

DELIVERY DEVICES AS THE NEW KEY TO PRODUCT SUCCESS

Jeannie Joughin describes how on-body delivery systems for the subcutaneous delivery of high volumes of viscous formulations can solve the challenges rapidly emerging as pharma companies advance their biologics pipelines.

A BLUETOOTH-CONNECTED WEARABLE, ON-BODY INJECTOR

In this article, we explore the vast potential for improving patient care that comes from adding connectivity to devices that deliver biotherapeutics for the treatment of chronic conditions.

GETTING TO KNOW ENABLE INJECTIONS

Here follow five mini-interviews with key Enable members. We asked each of them the same five questions, and their answers give interesting insights, from varied perspectives, into what really makes Enable Injections tic.

PEOPLE POWER: INSPIRING & DELIVERING A UNIQUE WEARABLE BOLUS INJECTOR

In this article we describe the highly customisable wearable bolus injection device developed by Enable Injections to provide the most comfortable, simple and discreet patient experience.

Top